{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:32:22Z","timestamp":1791772342926,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metab"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Adipose tissue metabolism may be impaired in patients with cancer. In particular, increased lipolysis was described in cancer-promoting adipose tissue atrophy.<\/jats:p>\n                <jats:p>For this reason, we assessed the expression of the lipolysis-associated genes and proteins in subcutaneous adipose tissue (SAT) of gastrointestinal (GI) cancer patients compared to controls to verify their involvement in cancer, among different types of GI cancers, and in cachexia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We considered patients with GI cancer (gastric, pancreatic, and colorectal) at their first diagnosis, with\/without cachexia, and controls with benign diseases.<\/jats:p>\n                <jats:p>We collected SAT and total RNA was extracted and ATGL, HSL, PPAR\u03b1, and MCP1 were analyzed by qRT-PCR. Western blot was performed to evaluate CGI-58, PLIN1 and PLIN5.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found higher expression of ATGL and HSL in GI cancer patients with respect to controls (<jats:italic>p<\/jats:italic> \u2264 0.008) and a trend of increase for PPAR\u03b1 (<jats:italic>p<\/jats:italic> = 0.055). We found an upregulation of ATGL in GI cancer patients with cachexia (<jats:italic>p<\/jats:italic> = 0.033) and without cachexia (<jats:italic>p<\/jats:italic> = 0.017) vs controls. HSL was higher in patients with cachexia (<jats:italic>p<\/jats:italic> = 0.020) and without cachexia (<jats:italic>p<\/jats:italic> = 0.021), compared to controls. ATGL was upregulated in gastric cancer vs controls (<jats:italic>p<\/jats:italic> = 0.014) and higher HSL was found in gastric (<jats:italic>p<\/jats:italic> = 0.008) and in pancreatic cancer (<jats:italic>p<\/jats:italic> = 0.033) vs controls. At the protein level, we found higher CGI-58 in cancer vs controls (<jats:italic>p<\/jats:italic> = 0.019) and in cachectic vs controls (<jats:italic>p<\/jats:italic> = 0.029), as well as in gastric cancer vs controls (<jats:italic>p<\/jats:italic> = 0.027).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In our cohort of GI cancer patients, we found a modulation in the expression of genes and proteins involved in lipolysis, and differences were interestingly detected according to cancer type.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40170-023-00329-9","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T13:02:26Z","timestamp":1704200546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessment of lipolysis biomarkers in adipose tissue of patients with gastrointestinal cancer"],"prefix":"10.1186","volume":"12","author":[{"given":"Federica","family":"Tambaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Imbimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Andreini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Belli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ida","family":"Amabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesarina","family":"Ramaccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lauteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Nigri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Muscaritoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Molfino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"329_CR1","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41591-023-02232-8","volume":"29","author":"O Al-Sawaf","year":"2023","unstructured":"Al-Sawaf O, Weiss J, Skrzypski M, Lam JM, Karasaki T, Zambrana F, et al. Body composition and lung cancer-associated cachexia in TRACERx. Nat Med. 2023;29:846\u201358.","journal-title":"Nat Med."},{"key":"329_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","volume":"20","author":"JM Argil\u00e9s","year":"2023","unstructured":"Argil\u00e9s JM, L\u00f3pez-Soriano FJ, Stemmler B, Busquets S. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol. 2023;20:250\u201364.","journal-title":"Nat Rev Clin Oncol."},{"key":"329_CR3","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539\u201347.","journal-title":"J Clin Oncol."},{"key":"329_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MCO.0000000000000923","volume":"26","author":"A Molfino","year":"2023","unstructured":"Molfino A, Imbimbo G, Muscaritoli M. Metabolic and histomorphological changes of adipose tissue in cachexia. Curr Opin Clin Nutr Metab Care. 2023;26:235\u201342.","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"329_CR5","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105.","journal-title":"Nat Rev Dis Primers."},{"key":"329_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jcsm.12893","volume":"13","author":"A Molfino","year":"2022","unstructured":"Molfino A, Carletti R, Imbimbo G, Amabile MI, Belli R, di Gioia CRT, et al. Histomorphological and inflammatory changes of white adipose tissue in gastrointestinal cancer patients with and without cachexia. J Cachexia Sarcopenia Muscle. 2022;13:333\u201342.","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"329_CR7","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/cancers14081948","volume":"14","author":"A Molfino","year":"2022","unstructured":"Molfino A, Belli R, Imbimbo G, Carletti R, Amabile MI, Tambaro F, et al. Evaluation of Browning Markers in Subcutaneous Adipose Tissue of Newly Diagnosed Gastrointestinal Cancer Patients with and without Cachexia. Cancers (Basel). 2022;14:1948.","journal-title":"Cancers (Basel)."},{"key":"329_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.21037\/apm.2018.10.01","volume":"8","author":"S Dalal","year":"2019","unstructured":"Dalal S. Lipid metabolism in cancer cachexia. Ann Palliat Med. 2019;8:13\u201323.","journal-title":"Ann Palliat Med."},{"key":"329_CR9","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s11010-022-04398-0","volume":"477","author":"M Joshi","year":"2022","unstructured":"Joshi M, Patel BM. The burning furnace: Alteration in lipid metabolism in cancer-associated cachexia. Mol Cell Biochem. 2022;477:1709\u201323.","journal-title":"Mol Cell Biochem."},{"key":"329_CR10","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/sj.bjc.6605665","volume":"102","author":"I Dahlman","year":"2010","unstructured":"Dahlman I, Mejhert N, Linder K, Agustsson T, Mutch DM, Kulyte A, et al. Adipose tissue pathways involved in weight loss of cancer cachexia. Br J Cancer. 2010;102:1541\u20138.","journal-title":"Br J Cancer."},{"key":"329_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/cncr.23802","volume":"113","author":"M Ryd\u00e9n","year":"2008","unstructured":"Ryd\u00e9n M, Agustsson T, Laurencikiene J, Britton T, Sj\u00f6lin E, Isaksson B, et al. Lipolysis--not inflammation, cell death, or lipogenesis--is involved in adipose tissue loss in cancer cachexia. Cancer. 2008;113:695\u20131704.","journal-title":"Cancer."},{"key":"329_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","volume":"29","author":"M Muscaritoli","year":"2010","unstructured":"Muscaritoli M, Anker SD, Argil\u00e9s J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \"cachexia-anorexia in chronic wasting diseases\" and \"nutrition in geriatrics\". Clin Nutr. 2010;29:154\u20139.","journal-title":"Clin Nutr."},{"key":"329_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol."},{"key":"329_CR14","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101\u20138.","journal-title":"Nat Protoc."},{"key":"329_CR15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1042\/BCJ20190468","volume":"477","author":"A Yang","year":"2020","unstructured":"Yang A, Mottillo EP. Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics. Biochem J. 2020;477:985\u20131008.","journal-title":"Biochem J."},{"key":"329_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.1198973","volume":"333","author":"SK Das","year":"2011","unstructured":"Das SK, Eder S, Schauer S, Diwoky C, Temmel H, Guertl B, et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science. 2011;333:233\u20138.","journal-title":"Science."},{"key":"329_CR17","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1038\/s41467-023-40024-3","volume":"14","author":"A Babic","year":"2023","unstructured":"Babic A, Rosenthal MH, Sundaresan TK, Khalaf N, Lee V, Brais LK, et al. Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. Nat Commun. 2023;14:4317.","journal-title":"Nat Commun."},{"key":"329_CR18","doi-asserted-by":"publisher","first-page":"79884","DOI":"10.18632\/oncotarget.20168","volume":"8","author":"M Muscaritoli","year":"2017","unstructured":"Muscaritoli M, Lucia S, Farcomeni A, Lorusso V, Saracino V, Barone C, et al. Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study. Oncotarget. 2017;8:79884\u201396.","journal-title":"Oncotarget."},{"key":"329_CR19","doi-asserted-by":"publisher","first-page":"599995","DOI":"10.3389\/fonc.2021.599995","volume":"11","author":"Y Tan","year":"2021","unstructured":"Tan Y, Wang M, Yang K, Chi T, Liao Z, Wei P. PPAR-\u03b1 Modulators as Current and Potential Cancer Treatments. Front Oncol. 2021;11:599995.","journal-title":"Front Oncol."},{"key":"329_CR20","doi-asserted-by":"publisher","first-page":"114311","DOI":"10.1016\/j.biopha.2023.114311","volume":"160","author":"X Zhao","year":"2023","unstructured":"Zhao X, Amevor FK, Cui Z, Wan Y, Xue X, Peng C, et al. Steatosis in metabolic diseases: A focus on lipolysis and lipophagy. Biomed Pharmacother. 2023;160:114311.","journal-title":"Biomed Pharmacother."},{"key":"329_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cyto.2011.10.008","volume":"57","author":"ML Batista Jr","year":"2012","unstructured":"Batista ML Jr, Peres SB, McDonald ME, Alcantara PS, Olivan M, Otoch JP, et al. Adipose tissue inflammation and cancer cachexia: possible role of nuclear transcription factors. Cytokine. 2012;57:9\u201316.","journal-title":"Cytokine."},{"key":"329_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/jcsm.12251","volume":"9","author":"EE Talbert","year":"2018","unstructured":"Talbert EE, Lewis HL, Farren MR, Ramsey ML, Chakedis JM, Rajasekera P, et al. Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-na\u00efve pancreatic cancer patients. J Cachexia Sarcopenia Muscle. 2018;9:358\u201368.","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"329_CR23","doi-asserted-by":"publisher","first-page":"826314","DOI":"10.3389\/fphys.2022.826314","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Li Z, Ngandiri DA, Llerins Perez M, Wolf A, Wang Y. The Molecular Brakes of Adipose Tissue Lipolysis. Front Physiol. 2022;13:826314.","journal-title":"Front Physiol."},{"key":"329_CR24","doi-asserted-by":"publisher","first-page":"R199","DOI":"10.1530\/JME-13-0277","volume":"52","author":"TS Nielsen","year":"2014","unstructured":"Nielsen TS, Jessen N, J\u00f8rgensen JO, M\u00f8ller N, Lund S. Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease. J Mol Endocrinol. 2014;52:R199\u2013222.","journal-title":"J Mol Endocrinol."},{"key":"329_CR25","doi-asserted-by":"publisher","first-page":"38310","DOI":"10.1038\/srep38310","volume":"6","author":"C Laurens","year":"2016","unstructured":"Laurens C, Bourlier V, Mairal A, Louche K, Badin PM, Mouisel E, et al. Perilipin 5 fine-tunes lipid oxidation to metabolic demand and protects against lipotoxicity in skeletal muscle. Sci Rep. 2016;6:38310.","journal-title":"Sci Rep."},{"key":"329_CR26","doi-asserted-by":"publisher","first-page":"886","DOI":"10.4161\/15384047.2014.987075","volume":"16","author":"KL Kliewer","year":"2015","unstructured":"Kliewer KL, Ke JY, Tian M, Cole RM, Andridge RR, Belury MA. Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice. Cancer Biol Ther. 2015;16:886\u201397.","journal-title":"Cancer Biol Ther."},{"key":"329_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12944-018-0657-0","volume":"17","author":"J Han","year":"2018","unstructured":"Han J, Meng Q, Shen L, Wu G. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning. Lipids Health Dis. 2018;17:14.","journal-title":"Lipids Health Dis."},{"key":"329_CR28","doi-asserted-by":"publisher","first-page":"5531","DOI":"10.1158\/0008-5472.CAN-06-4585","volume":"67","author":"T Agustsson","year":"2007","unstructured":"Agustsson T, Ryd\u00e9n M, Hoffstedt J, van Harmelen V, Dicker A, Laurencikiene J, et al. Mechanism of increased lipolysis in cancer cachexia. Cancer Res. 2007;67:5531\u20137.","journal-title":"Cancer Res."},{"key":"329_CR29","doi-asserted-by":"publisher","first-page":"1123567","DOI":"10.3389\/fonc.2023.1123567","volume":"13","author":"R Fang","year":"2023","unstructured":"Fang R, Yan L, Liao Z. Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy. Front Oncol. 2023;13:1123567.","journal-title":"Front Oncol."},{"key":"329_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36:11\u201348.","journal-title":"Clin Nutr."},{"key":"329_CR31","doi-asserted-by":"publisher","first-page":"997813","DOI":"10.3389\/fnut.2022.997813","volume":"9","author":"A Molfino","year":"2023","unstructured":"Molfino A, Emerenziani S, Tonini G, Santini D, Gigante A, Guarino MPL, et al. Early impairment of food intake in patients newly diagnosed with cancer. Front Nutr. 2023;9:997813.","journal-title":"Front Nutr."},{"issue":"23","key":"329_CR32","first-page":"00155","volume":"S0261-5614","author":"M Muscaritoli","year":"2023","unstructured":"Muscaritoli M, Imbimbo G, Jager-Wittenaar H, Cederholm T, Rothenberg E, di Girolamo FG, et al. Disease-related malnutrition with inflammation and cachexia. Clin Nutr. 2023;S0261-5614(23):00155\u20133.","journal-title":"Clin Nutr."},{"key":"329_CR33","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/jcsm.12918","volume":"13","author":"LJ Anderson","year":"2022","unstructured":"Anderson LJ, Lee J, Anderson B, Lee B, Migula D, Sauer A, et al. Whole-body and adipose tissue metabolic phenotype in cancer patients. J Cachexia Sarcopenia Muscle. 2022;13:1124\u201333.","journal-title":"J Cachexia Sarcopenia Muscle."}],"container-title":["Cancer &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-023-00329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40170-023-00329-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40170-023-00329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T13:16:35Z","timestamp":1704201395000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerandmetabolism.biomedcentral.com\/articles\/10.1186\/s40170-023-00329-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["329"],"URL":"https:\/\/doi.org\/10.1186\/s40170-023-00329-9","relation":{},"ISSN":["2049-3002"],"issn-type":[{"value":"2049-3002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"29 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the Declaration of Helsinki and approved by the local Ethics Committee (Sapienza University, Azienda Sant\u2019Andrea Hospital, Rome, Italy\u2014prot. n. 167_2017). Written informed consent was obtained by all cancer patients and controls enrolled in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}